Home
>
National Drug Code (NDC)
>
Norvir
Norvir - 0074-3333-30 - (Ritonavir)
Drug Information of Norvir
| Product NDC: | 0074-3333 |
| Proprietary Name: | Norvir |
| Non Proprietary Name: | Ritonavir |
| Active Ingredient(s): | 100 mg/1 & nbsp; Ritonavir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Norvir
| Product NDC: | 0074-3333 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022417 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100506 |
Package Information of Norvir
| Package NDC: | 0074-3333-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0074-3333-30) |
NDC Information of Norvir
| NDC Code | 0074-3333-30 |
| Proprietary Name | Norvir |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0074-3333-30) |
| Product NDC | 0074-3333 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ritonavir |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100506 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | RITONAVIR |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
